UFP Technologies, Inc. (UFPT)

In the past six months, UFP Technologies reported its first-quarter 2026 financial results with net sales increasing by 4.1% and net income rising by 1.8%. Medical market sales grew by 5.9%. Despite beating adjusted EPS estimates, the stock hit a new 52-week low. Management highlighted strong momentum in its MedTech business and announced plans to increase capacity with two new facilities in the Dominican Republic. An amended supply agreement with Intuitive Surgical was also a notable development. The company acknowledged near-term headwinds, including seasonality, program phasing, softer non-medical demand, and start-up expenses. A cyber incident in February 2026 also incurred non-recurring legal expenses. Analyst ratings generally maintain a "Hold" consensus.

UFP Technologies has acknowledged seasonality as a near-term headwind in its business operations. The company's Q1 2026 earnings call indicated that working capital dynamics limited near-term cash flow due to a strong March sales month driving higher working capital needs. The company's increasing focus on the medical sector may mitigate some seasonal fluctuations. However, the acknowledgment of seasonality suggests that demand for its products and services can fluctuate throughout the year.

UFP Technologies specializes in comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, with its MedTech business accounting for over 90% of its revenue. The company designs and manufactures single-use medical devices, components, and packaging for applications such as minimally invasive surgery, infection prevention, and wound care. UFP Technologies also provides products to the automotive, aerospace and defense, consumer, electronics, and industrial markets, utilizing manufacturing processes like laminating, molding, and welding.

UFP Technologies operates manufacturing facilities across North America, including the United States, Mexico, and Canada. In the United States, the company has locations in Alabama, California, Colorado, Florida, Georgia, Illinois, Maryland, Massachusetts, Michigan, New Hampshire, Puerto Rico, Rhode Island, and Texas. Internationally, UFP Technologies has expanded to five countries, with operations in Tijuana, Mexico, Orillia, Ontario, Canada, and additional facilities in Ireland, Costa Rica, Dominican Republic, and Singapore. The company also manages international supply chains to support its global customer base.

UFP Technologies' brand reputation has been primarily shaped by its strong financial performance and strategic focus on the medical sector. The company's consistent growth in medical sales and its role as a valued outsourcing partner contribute positively to its reputation. A cybersecurity incident detected on February 14, 2026, involving unauthorized access to its IT systems, affected functions like billing and label making. While operations continued with minimal material impact, UFP Technologies is still investigating the extent of data exfiltration and cautions about future cybersecurity risks.

UFP Technologies' ownership is predominantly institutional, with 268 institutional owners and shareholders holding a total of 8,657,448 shares as of April 9, 2026. Major institutional owners include BlackRock, Inc., Wasatch Advisors Inc, and Vanguard Group Inc. Institutional investors and hedge funds collectively own a substantial portion of the stock. Insider ownership stood at approximately 3.73% as of August 21, 2025, with William Shaw identified as a significant individual shareholder.